Position in ACET
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$522,815
+$110,736 QoQ
Shares Held
60,511
0.0% QoQ
Ownership
0.646%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#23
of 56 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACET Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026REGENERON PHARMACEUTICALS, INC. holds $177,219,138 across 3 Biotechnology names. ACET ranks #3 (0.3% of the industry book) .
All Filings in ACET
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $522,815 | 60,511 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $412,079 | 60,511 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $509,502 | 60,511 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $784,228 | 968,183 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $590,591 | 968,183 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $730,978 | 968,183 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $931,392 | 968,183 | Shares | Sole | 2025-02-07 | |
| No filing history on record for this holder in this stock. | ||||||